Diagnosis

Pseudomembranous colitis

An acute colitis characterized by formation of an adherent inflammatory exudate (pseudomembrane) overlying the site of mucosal injury.

Also known as: Clostridioides difficile infection, Clostridium difficile colitis

Etiology

Cause [kht]

Pathophysiology [kht]

  1. The gastrointestinal tract microbial community (microbiome) is vital for:

    • Food fermentation

    • Barrier against pathogens

    • Synthesizing vitamins

    • Regulating metabolism and immunity

  2. Colonization of C difficile in 4% of healthy individuals without causing infections

  3. Antibiotic usage (penicillin, cephalosporin, fluoroquinolone, clindamycin)

  4. A disturbance of the normal bacterial flora of the colon

  5. Overgrowth of C difficile --> dysbiosis ==> colonisation --> infection

  6. Release of toxins that cause:

    • Mucosal inflammation and damage

    • Diarrhea: ≥3 loose stools within 24 hours

Risk factors [rts][kht]

Complications [kht]

Epidemiology

Incidence per 100.000 [e3w][y3w][5oc][rqg][gm9]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Anorexia, Diarrhea, Fever, Malaise

Clinical findings

Decreased Albumin, Elevated Lactate, Leukocytosis

Anamneses

Antibiotics

Localized findings

Pain
Radiates
Abdomen
Onset
Gradual (days)
Pattern
Constant
Quality
Cramping
Severity
Mild (1-3)Moderate (4-7)

Approach

Treatment

  1. Replacement of fluid and electrolyte losses [1q2][v94][rts]

  2. Avoidance of antiperistaltic agents: opiates, loperamide

  3. Discontinuation of antimicrobial therapy if possible

  4. If severe symptomatic disease --> Metronidazole 500mg x 3 or Vancomycim (oral)

    • Alternatives: Fidaxomicin, bacitracin, teicoplanin, oral fusidic acid

    • Fecal microbiota transplantation

  5. Fulminant collitis --> subtotal or total colectomy

Differential diagnoses

Abdominal abscess, Cholera, Coliac disease, Crohn disease, Diverticulitis, Gastroenteritis, Gastrointestinal perforation, Irritable bowel syndrome, Peritonitis, Salmonellosis, Shigellosis, Toxic megacolon, Ulcerative colitis


References

[1] Mada PK, Alam MU. Clostridioides difficile infection. [Updated 2024 Apr 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431054/

[2] Khanna S, Pardi DS. Clostridium difficile infection: new insights into management. Mayo Clin Proc. 2012 Nov;87(11):1106-17.

[3] Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012 Jan;107(1):89-95.

[4] Health Protection Surveillance Centre (HPSC) Annual Report 2008: 9.5 Clostridium difficile-associated disease in Ireland.

[5] Centers for Disease Control and Prevention. Emerging Infections Program, Healthcare Associated Infections Community interface surveillance report, Clostridioides difficile infection (CDI), 2019. https://www.cdc.gov/hai/eip/pdf/cdiff/2019-CDI-Report-H.pdf

[6] Solanki D, Kichloo A, El-Amir Z, Dahiya DS, Singh J, Wani F, Solanki S. Clostridium difficile Infection Hospitalizations in the United States: Insights From the 2017 National Inpatient Sample. Gastroenterology Res. 2021 Apr;14(2):87-95.

[7] 2019 Annual Report for the Emerging Infections Program for Clostridioides difficile Infection

[8] Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE; SHEA Long-Term-Care Committee. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol. 2002 Nov;23(11):696-703.

[9] http://emedicine.medscape.com/article/186458 (2014-01-02); [Medscape]

Scroll to top